Keep Me Logged In
Merrimack Pharmaceuticals develops products to treat cancer. President and CEO Bob Mulroy, shares his view of drug price hikes and whether the FDA is in the way of companies.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2018 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by